Sinco Pharmaceuticals Holdings 過去の業績
過去 基準チェック /46
Sinco Pharmaceuticals Holdingsは、平均年間20.1%の収益成長を遂げていますが、 Healthcare業界の収益は、年間 成長しています。収益は、平均年間11.2% 16.9%収益成長率で 成長しています。 Sinco Pharmaceuticals Holdingsの自己資本利益率は7.2%であり、純利益率は1.6%です。
主要情報
20.1%
収益成長率
18.5%
EPS成長率
| Healthcare 業界の成長 | 11.3% |
| 収益成長率 | 16.9% |
| 株主資本利益率 | 7.2% |
| ネット・マージン | 1.6% |
| 前回の決算情報 | 30 Jun 2024 |
最近の業績更新
Recent updates
What Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 32% Share Price Gain Is Not Telling You
Oct 04
Risks To Shareholder Returns Are Elevated At These Prices For Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Aug 16Some Investors May Be Willing To Look Past Sinco Pharmaceuticals Holdings' (HKG:6833) Soft Earnings
Apr 02Sinco Pharmaceuticals Holdings Limited (HKG:6833) Might Not Be As Mispriced As It Looks
Mar 08Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?
Nov 07A Look At The Intrinsic Value Of Sinco Pharmaceuticals Holdings Limited (HKG:6833)
Jun 26Does Sinco Pharmaceuticals Holdings (HKG:6833) Have A Healthy Balance Sheet?
May 30Sinco Pharmaceuticals Holdings (HKG:6833) Has A Pretty Healthy Balance Sheet
Oct 26Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Might Deserve Your Attention Today
Feb 04I Ran A Stock Scan For Earnings Growth And Sinco Pharmaceuticals Holdings (HKG:6833) Passed With Ease
Oct 25Little Excitement Around Sinco Pharmaceuticals Holdings Limited's (HKG:6833) Earnings
Jun 10Sinco Pharmaceuticals Holdings (HKG:6833) Could Easily Take On More Debt
May 24Here's Why I Think Sinco Pharmaceuticals Holdings (HKG:6833) Is An Interesting Stock
Apr 20We're Not So Sure You Should Rely on Sinco Pharmaceuticals Holdings' (HKG:6833) Statutory Earnings
Feb 16How Much Did Sinco Pharmaceuticals Holdings'(HKG:6833) Shareholders Earn From Share Price Movements Over The Last Three Years?
Jan 11
Should You Be Excited About Sinco Pharmaceuticals Holdings Limited's (HKG:6833) 51% Return On Equity?
Dec 07収支内訳
収支内訳
Sinco Pharmaceuticals Holdings の稼ぎ方とお金の使い方。LTMベースの直近の報告された収益に基づく。
収益と収入の歴史
| 日付 | 収益 | 収益 | G+A経費 | 研究開発費 |
|---|---|---|---|---|
| 30 Jun 24 | 2,977 | 47 | 212 | 0 |
| 31 Mar 24 | 2,758 | 44 | 210 | 0 |
| 31 Dec 23 | 2,540 | 42 | 207 | 0 |
| 30 Sep 23 | 2,386 | 35 | 196 | 0 |
| 30 Jun 23 | 2,232 | 27 | 190 | 0 |
| 31 Mar 23 | 2,252 | 48 | 197 | 0 |
| 31 Dec 22 | 2,272 | 69 | 205 | 0 |
| 30 Sep 22 | 2,289 | 96 | 218 | 0 |
| 30 Jun 22 | 2,307 | 122 | 232 | 0 |
| 31 Mar 22 | 2,165 | 128 | 202 | 0 |
| 31 Dec 21 | 2,024 | 135 | 172 | 0 |
| 30 Sep 21 | 2,142 | 148 | 137 | 0 |
| 30 Jun 21 | 2,261 | 161 | 102 | 0 |
| 31 Mar 21 | 2,155 | 140 | 116 | 0 |
| 31 Dec 20 | 2,050 | 118 | 130 | 0 |
| 30 Sep 20 | 1,664 | 79 | 150 | 0 |
| 30 Jun 20 | 1,277 | 41 | 170 | 0 |
| 31 Mar 20 | 1,227 | 32 | 166 | 0 |
| 31 Dec 19 | 1,176 | 24 | 162 | 0 |
| 30 Sep 19 | 1,045 | -97 | 206 | 0 |
| 30 Jun 19 | 915 | -217 | 251 | 0 |
| 31 Mar 19 | 934 | -249 | 288 | 0 |
| 31 Dec 18 | 953 | -281 | 325 | 0 |
| 30 Sep 18 | 960 | -242 | 292 | 0 |
| 30 Jun 18 | 966 | -203 | 258 | 0 |
| 31 Mar 18 | 886 | -195 | 206 | 0 |
| 31 Dec 17 | 807 | -186 | 153 | 0 |
| 30 Sep 17 | 755 | -115 | 115 | 0 |
| 30 Jun 17 | 704 | -43 | 77 | 0 |
| 31 Mar 17 | 781 | -12 | 75 | 0 |
| 31 Dec 16 | 859 | 19 | 74 | 0 |
| 30 Sep 16 | 958 | 36 | 71 | 0 |
| 30 Jun 16 | 1,057 | 52 | 67 | 0 |
| 31 Mar 16 | 1,076 | 61 | 57 | 0 |
| 31 Dec 15 | 1,096 | 70 | 46 | 0 |
| 30 Sep 15 | 1,120 | 77 | 38 | 0 |
| 30 Jun 15 | 1,144 | 84 | 31 | 0 |
| 31 Mar 15 | 1,047 | 77 | 28 | 0 |
| 31 Dec 14 | 950 | 69 | 24 | 0 |
| 31 Dec 13 | 532 | 37 | 12 | 0 |
質の高い収益: 6833 非現金収入 のレベルが高いです。
利益率の向上: 6833の現在の純利益率 (1.6%)は、昨年(1.2%)よりも高くなっています。
フリー・キャッシュフローと収益の比較
過去の収益成長分析
収益動向: 6833過去 5 年間で収益を上げており、収益は年間20.1%増加しています。
成長の加速: 6833の過去 1 年間の収益成長率 ( 71.8% ) は、5 年間の平均 ( 年間20.1%を上回っています。
収益対業界: 6833の過去 1 年間の収益成長率 ( 71.8% ) はHealthcare業界-16.9%を上回りました。
株主資本利益率
高いROE: 6833の 自己資本利益率 ( 7.2% ) は 低い とみなされます。